Illinois CancerCare-Dixon — Dixon, Illinois

Illinois CancerCare-Dixon is a clinical research site located in Dixon, Illinois, United States 61021.

Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.

Illinois CancerCare-Dixon has participated in 193 clinical trials with 165 currently active.

Therapeutic areas: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dixon

Browse all research sites in Illinois · View every site in Dixon

Sponsor Feasibility Report

Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Illinois CancerCare-Dixon?

Illinois CancerCare-Dixon has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Illinois CancerCare-Dixon conducted?

Illinois CancerCare-Dixon has 193 clinical trials on record, with 165 currently active. Their work covers Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.

Is Illinois CancerCare-Dixon accredited by Crixeo Clinical Trials?

Illinois CancerCare-Dixon has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Illinois CancerCare-Dixon?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.